Purchases and Sales Made in Q2 2022 in Nuvectis Pharma, Inc. (NVCT)
This table provides information about the institutional ownership of Nuvectis Pharma, Inc. (NVCT) during Q2 2022. The information is specifically focused on institutions that hold shares of Nuvectis Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jul 18, 2022
Q2 2022
|
Baldwin Brothers LLC
|
BUY
|
- |
121KNew |
$849K - $2.47M
|
121K
$569K
|
|
|
Aug 12, 2022
Q2 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
23.3KNew |
$163K - $475K
|
23.3K
$109K
|
|
|
Aug 15, 2022
Q2 2022
|
State Street Corp
Boston, MA |
BUY
|
- |
11.7KNew |
$82.1K - $239K
|
11.7K
$55K
|
|
|
Aug 12, 2022
Q2 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
9.15K+ 61.7% |
$64.2K - $187K
|
24K
$113K
|
|
|
Aug 15, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
200New |
$1.4K - $4.09K
|
200
$940
|
|
|
Aug 12, 2022
Q2 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 5.0% |
$7.02 - $20.4
|
21
$98.7
|
|
|
Aug 09, 2022
Q2 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
SELL
|
- |
-79- 56.03% |
$555 - $1.61K
|
62
$291
|
|
|
Aug 15, 2022
Q2 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-471- 26.91% |
$3.31K - $9.63K
|
1.28K
$6.01K
|
|
|
Aug 12, 2022
Q2 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-674- 8.56% |
$4.73K - $13.8K
|
7.2K
$33.8K
|
|
|
Aug 09, 2022
Q2 2022
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-11.4KClosed |
$79.8K - $232K
|
0
$0
|
|
|
Aug 04, 2022
Q2 2022
|
Ronit Capital LLP
|
SELL
|
- |
-131K- 23.77% |
$918K - $2.67M
|
419K
$1.97M
|